Literature DB >> 3920902

Heterogeneity of holocarboxylase synthetase in patients with biotin-responsive multiple carboxylase deficiency.

B J Burri, L Sweetman, W L Nyhan.   

Abstract

Holocarboxylase synthetase activity has been determined in fibroblasts of seven patients with the neonatal form of biotin-responsive multiple carboxylase deficiency. The normal Km for biotin was 15 +/- 3 nmol/l, while in the patients the values ranged from 48 to 1,062 nmol/l. The mean maximum velocity was 27% of normal. Differences among the values obtained for the Km for biotin and the heat stability of holocarboxylase synthetase suggested that the patients studied represented at least four distinct variants at the holocarboxylase synthetase locus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920902      PMCID: PMC1684574     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Biotin-responsive beta-methylcrotonylglycinuria.

Authors:  D Gompertz; G H Draffan; J L Watts; D Hull
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

2.  Combined carboxylase defect: biotin-responsiveness in cultured fibroblasts.

Authors:  K Bartlett; D Gompertz
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

3.  A combined defect of three mitochondrial carboxylases presenting as biotin-responsive 3-methylcrotonyl glycinuria and 3-hydroxyisovaleric aciduria.

Authors:  K Bartlett; H Ng; J V Leonard
Journal:  Clin Chim Acta       Date:  1980-01-15       Impact factor: 3.786

4.  Propionyl-CoA carboxylase deficiency in a patient with biotin-responsive 3-methylcrotonylglycinuria.

Authors:  L Sweetman; S P Bates; D Hull; W L Nyhan
Journal:  Pediatr Res       Date:  1977-11       Impact factor: 3.756

5.  Biotin-response organicaciduria. Multiple carboxylase defects and complementation studies with propionicacidemia in cultured fibroblasts.

Authors:  M Saunders; L Sweetman; B Robinson; K Roth; R Cohn; R A Gravel
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

6.  Beta-methylcrotonic aciduria associated with lactic acidosis.

Authors:  K Roth; R Cohn; J Yandrasitz; G Preti; P Dodd; S Segal
Journal:  J Pediatr       Date:  1976-02       Impact factor: 4.406

7.  Holocarboxylase synthetase deficiency: a biotin-responsive organic acidemia.

Authors:  K S Roth; W Yang; J W Foremann; R Rothman; S Segal
Journal:  J Pediatr       Date:  1980-05       Impact factor: 4.406

8.  Multiple biotin-dependent carboxylase deficiencies associated with defects in T-cell and B-cell immunity.

Authors:  M J Cowan; D W Wara; S Packman; A J Ammann; M Yoshino; L Sweetman; W Nyhan
Journal:  Lancet       Date:  1979-07-21       Impact factor: 79.321

9.  Biotin-responsive carboxylase deficiency associated with subnormal plasma and urinary biotin.

Authors:  J Thoene; H Baker; M Yoshino; L Sweetman
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

10.  Deficiency of propionyl-Co A carboxylase and methylcrotonyl-Co A carboxylase in a patient with methylcrotonylglycinuria.

Authors:  W Weyler; L Sweetman; D C Maggio; W L Nyhan
Journal:  Clin Chim Acta       Date:  1977-05-02       Impact factor: 3.786

View more
  16 in total

1.  Biotinidase deficiency: metabolites in CSF.

Authors:  A Fois; M Cioni; P Balestri; G Bartalini; R Baumgartner; C Bachmann
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 2.  Antenatal and postnatal radiologic diagnosis of holocarboxylase synthetase deficiency: a systematic review.

Authors:  Sahan P Semasinghe Bandaralage; Soheil Farnaghi; Joel M Dulhunty; Alka Kothari
Journal:  Pediatr Radiol       Date:  2016-01-11

3.  A new case of holocarboxylase synthetase deficiency.

Authors:  P Briones; A Ribes; M A Vilaseca; G Rodríguez-Valcárcel; L P Thuy; L Sweetman
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 4.  Holocarboxylase synthetase deficiency: 9-year follow-up of a patient on chronic biotin therapy and a review of the literature.

Authors:  A J Michalski; G T Berry; S Segal
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Holocarboxylase synthetase is an obligate participant in biotin-mediated regulation of its own expression and of biotin-dependent carboxylases mRNA levels in human cells.

Authors:  R Sergio Solórzano-Vargas; Diana Pacheco-Alvarez; Alfonso León-Del-Río
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

6.  Acylcarnitine profile in tissues and body fluids of biotin-deficient rats with and without L-carnitine supplementation.

Authors:  Y Shigematsu; I L Bykov; Y Y Liu; A Nakai; Y Kikawa; M Sudo; M Fujioka
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

7.  Holocarboxylase synthetase deficiency: early diagnosis and management of a new case.

Authors:  A Fuchshuber; T Suormala; B Roth; M Duran; D Michalk; E R Baumgartner
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

Review 8.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

9.  Impaired biotinidase activity disrupts holocarboxylase synthetase expression in late onset multiple carboxylase deficiency.

Authors:  Anylu Pérez-Monjaras; Rafael Cervantes-Roldán; Iván Meneses-Morales; Roy A Gravel; Sandra Reyes-Carmona; Sergio Solórzano-Vargas; Alfonso González-Noriega; Alfonso León-Del-Río
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

10.  Management of a patient with holocarboxylase synthetase deficiency.

Authors:  Johan L K Van Hove; Sagi Josefsberg; Cynthia Freehauf; Janet A Thomas; Le Phuc Thuy; Bruce A Barshop; Michael Woontner; Donald M Mock; Pei-Wen Chiang; Elaine Spector; Iván Meneses-Morales; Rafael Cervantes-Roldán; Alfonso León-Del-Río
Journal:  Mol Genet Metab       Date:  2008-10-29       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.